Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetylator phenotypes: effect of age.

B Gachályi, A Vas, P Hajós

    European Journal of Clinical Pharmacology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Within-Year Effects of Prescribed Fire on Bumble Bees (Hymenoptera: Apidae) and Floral Resources.

    Journal of insect science (Online)·2022
    Same author

    Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone.

    International journal of STD & AIDS·2013
    Same author

    Autoimmune limbic encephalitis.

    Clinical medicine (London, England)·2012
    Same author

    C60La: a deflated soccer ball?

    Journal of the American Chemical Society·2011
    Same author

    Correlation between crossed cerebellar diaschisis and clinical neurological scales.

    Acta neurologica Scandinavica·2011
    Same author

    Autoimmune encephalitis: a case series and comprehensive review of the literature.

    QJM : monthly journal of the Association of Physicians·2011

    Age influences drug acetylation rates. In Hungarians, slow acetylator phenotypes predominated in the elderly, unlike younger individuals, suggesting age impacts hepatic drug metabolism.

    Area of Science:

    • Pharmacogenetics
    • Drug Metabolism
    • Human Physiology

    Background:

    • Acetylator phenotype, particularly concerning the cytochrome P450 enzyme CYP2D6, is crucial for drug metabolism.
    • Genetic variations influence acetylator phenotypes, affecting drug efficacy and safety.
    • Previous studies have indicated potential age-related differences in drug metabolism, but specific data on acetylator phenotypes in elderly populations remain limited.

    Purpose of the Study:

    • To investigate the distribution of acetylator phenotypes in a Hungarian population.
    • To determine if age influences the prevalence of different acetylator phenotypes.
    • To explore the implications of these findings for hepatic drug acetylation rates in the elderly.

    Main Methods:

    • Phenotyping of acetylator status in 253 Caucasian individuals from a Hungarian population.

    Related Experiment Videos

  • Stratification of participants into two age groups: elderly (over 60 years) and young (below 60 years).
  • Statistical analysis to compare the distribution of acetylator phenotypes between the age groups and the overall population.

    • Main Results:

    • The overall Hungarian population studied showed an equal proportion of fast and slow acetylator phenotypes.
    • Individuals below 60 years of age also exhibited an equal distribution of both acetylator phenotypes.
    • In contrast, the elderly group (over 60 years) showed a predominance of the slow acetylator phenotype.

    Conclusions:

    • The study findings support the hypothesis that age significantly influences hepatic drug acetylation rates.
    • The increased prevalence of slow acetylators in the elderly Hungarian population suggests altered drug metabolism in this demographic.
    • These results highlight the importance of considering age-specific pharmacogenetics for optimizing drug therapy in older individuals.